Lyme disease aftercare: new insights into persistent symptoms

Study explores the causes of persistent symptoms after Lyme borreliosis (LB) treatment, revealing that factors like social and physical functioning, psychological distress, and comorbidities are key determinants.

KBI Biopharma and Argonaut form drug manufacturing alliance

Share this article The new alliance will offer end-to-end drug manufacturing solutions for biopharmaceutical companies. Credit: IM Imagery / Shutterstock.com. Contract development and manufacturing organisations

January 17, 2024

California pays meth users to get sober

Here in the rugged foothills of California’s Sierra Nevada, the streets aren’t littered with needles and dealers aren’t hustling drugs on the corner.

May 22, 2024

New API Facility in Ankleshwar Receives USFDA GMP Approval

Rusan Pharma’s new facility paves the way for the company to expand their global market reach. RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in

July 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.